PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. [electronic resource]
Producer: 20120329Description: 5761-9 p. digitalISSN:- 1098-6596
- Anti-Bacterial Agents -- pharmacology
- Bacterial Proteins -- genetics
- Colistin -- pharmacology
- Cystic Fibrosis -- drug therapy
- Drug Resistance, Bacterial -- genetics
- Female
- Humans
- Lipid A -- chemistry
- Male
- Microbial Sensitivity Tests
- Mutation
- Polymyxins -- pharmacology
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.